2026-07-132 min
Sermorelin: Healthy-Aging Claims and Evidence Boundaries
An evidence-led Sermorelin review focused on healthy-aging claims, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review DeskEditorial desk
Regulatory Review Desk
Regulatory Research EditorsThe Regulatory Review Desk tracks FDA compounding materials, approval history, product labeling and other public regulatory records.
35 published notesEvidence notes
Open
2026-07-122 min
Sermorelin: Sleep Claims and Evidence Boundaries
An evidence-led Sermorelin review focused on sleep claims, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk2026-07-122 min
Sermorelin: Body Composition Claims and Evidence Boundaries
An evidence-led Sermorelin review focused on body composition claims, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk2026-07-102 min
Sermorelin: WADA and Sport Rules and Evidence Boundaries
An evidence-led Sermorelin review focused on wada and sport rules, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk2026-07-102 min
Sermorelin: Product Identity and Purity and Evidence Boundaries
An evidence-led Sermorelin review focused on product identity and purity, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk2026-07-092 min
Sermorelin: Population Generalizability and Evidence Boundaries
An evidence-led Sermorelin review focused on population generalizability, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk2026-07-052 min
Ipamorelin: Small-Study Statistics and Evidence Boundaries
An evidence-led Ipamorelin review focused on small-study statistics, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk2026-07-042 min
Ipamorelin: Combination Evidence Test and Evidence Boundaries
An evidence-led Ipamorelin review focused on combination evidence test, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk2026-07-012 min
Ipamorelin: Receptor Pathway Map and Evidence Boundaries
An evidence-led Ipamorelin review focused on receptor pathway map, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk